The First Web 2.0 Pharmaceutical News Portal

World Pharma News project is launching a Web 2.0 pharmaceutical news platform, named as well World Pharma News but with attached '.net' extension. Web 2.0 generally represents knowledge-oriented social-networking platforms focused first of all on collaborative approaches.

"We know that it is a very ambitious initiative but we trust in the power and in the flexibility of the coming Web 2.0 pharmaceutical solutions/interfaces, we sincerely hope that in the nearest future the term 'Pharma 2.0' will sound as well appropriate as the terms Web 2.0 or Health 2.0", assumed World Pharma News .net administrator.

World Pharma News .net, by being based on the well known open source software, is following the Web 2.0 strategy of hosting, supporting and motivating the online content submission (pharmaceutical news articles). Additionally, the launched platform looks very similar to the known Digg.com presence. The main differences are the design and in special the targeted pharmaceutical sector which makes World Pharma News .net the first worldwide Web 2.0 pharmaceutical news platform.

"All Internet users interested in the next appearance of the 'pharma' domain, called by us 'Pharma 2.0', are very welcome to explore World Phamra News .net and in special to register, submit or to vote the collected and published news articles", said project administrator.

For further information, please visit:
http://www.worldpharmanews.net

About World Pharma News .net
World Pharma News .net is an advanced Web 2.0 pharmaceutical news portal developed on the top of the World Pharma News .com Project. For further information, please visit www.worldpharmanews.net.

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...